- Home
- AGAE vs CRIS Comparison
AGAE vs CRIS Comparison
Compare AGAE & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.37
HOLD
Current Price
$1.35
Company Overview
Basic Information| Metric | AGAE | CRIS |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 14.6M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | AGAE | CRIS |
|---|---|---|
| Price | $0.37 | $1.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | ★ 1.1M | 110.3K |
| Earning Date | 11-19-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,938,232.00 | ★ $11,650,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $8.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $0.34 | $1.02 |
| 52 Week High | $3.79 | $4.50 |
Technical Indicators
Market Signals| Indicator | AGAE | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 51.03 |
| Support Level | $0.34 | $1.29 |
| Resistance Level | $0.42 | $1.41 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 24.67 | 73.55 |
Price Performance
Historical Comparison AGAE
CRIS
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.